- impaired macrophage phagocytosis / MGI
- decreased inflammatory response / MGI
- increased susceptibility to bacterial infection / MGI
- abnormal cell-mediated immunity / MGI
- abnormal macrophage physiology / MGI
- abnormal macrophage antigen presentation / MGI
- abnormal dendritic cell antigen presentation / MGI
- increased IgG level / MGI
- abnormal type I hypersensitivity reaction / MGI
- decreased susceptibility to induced arthritis / MGI
- decreased susceptibility to autoimmune hemolytic anemia / MGI
- abnormal dendritic cell differentiation / MGI
STOCK Fcgr1tm1Jsv/Cnrm
Status | Available to order |
EMMA ID | EM:02540 |
Citation information | RRID:IMSR_EM:02540 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | STOCK Fcgr1tm1Jsv/Cnrm |
Alternative name | CD64 KO on C57Bl6 |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Fcgr1tm1Jsv |
Gene/Transgene symbol | Fcgr1 |
Information from provider
Provider | Joseph Verbeek |
Provider affiliation | Human Genetics, Leiden University Medical Center (LUMC) |
Genetic information | Deletion of 3'-part of promoter, exon 1 (L1 domain), exon 2 (L2 domain) and 5'-part of exon 3 (ligand binding EC1 domain), replaced by PGK-hygromycin resistance cassette. |
Phenotypic information | Impaired IgG2a antibody effector pathways. |
Breeding history | Generated with E14 129P2 ES cell line; F1-F2: C57BL/6 F3-F4 BALB/c F5-F12: C57BL/6 |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | yes |
Information from EMMA
Archiving centre | CNR, Consiglio Nazionale delle Ricerche, Monterotondo, Italy |
Disease and phenotype information
MGI phenotypes (gene matching)
Literature references
- FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.;Ioan-Facsinay A, de Kimpe S J, Hellwig S M M, van Lent P L, Hofhuis F M A, van Ojik H H, Sedlik C, da Silveira S A, Gerber J, de Jong Y F, Roozendaal R, Aarden L A, van den Berg W B, Saito T, Mosser D, Amigorena S, Izui S, van Ommen G J B, van Vugt M, van de Winkel J G J, Verbeek J S, ;2002;Immunity;16;391-402; 11911824
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).